drospirenone and ethinyl estradiol combination has been researched along with Compensatory Hyperinsulinemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguiar, GS; Bonfleur, ML; Boschero, AC; Clarke, JR; da Silva Junior, JA; Dos Reis Araujo, T; Freitas, IN; Henriques, HN; Oliveira, CAR; Oliveira, KM; Ribeiro, RA; Vettorazzi, JF | 1 |
Apa, R; Ciardulli, A; Cosentino, N; Crea, F; Familiari, A; Lanzone, A; Liuzzo, G; Martinez, D; Morciano, A; Moro, F; Niccoli, G; Palla, C; Sagnella, F; Scarinci, E; Tritarelli, A; Tropea, A | 1 |
de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A | 1 |
2 trial(s) available for drospirenone and ethinyl estradiol combination and Compensatory Hyperinsulinemia
Article | Year |
---|---|
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial.
Topics: Adolescent; Adult; Analysis of Variance; Androstenes; Cardiovascular Diseases; CD28 Antigens; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Chi-Square Distribution; Ethinyl Estradiol; Female; Humans; Hyperinsulinism; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Rome; Time Factors; Treatment Outcome; Young Adult | 2013 |
Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess.
Topics: Adolescent; Androgen Antagonists; Androstenes; Body Composition; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Flutamide; Follistatin; Humans; Hyperandrogenism; Hyperinsulinism; Metformin; Young Adult | 2011 |
1 other study(ies) available for drospirenone and ethinyl estradiol combination and Compensatory Hyperinsulinemia
Article | Year |
---|---|
Combined oral contraceptive in female mice causes hyperinsulinemia due to β-cell hypersecretion and reduction in insulin clearance.
Topics: Androstenes; Animals; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose; Hyperinsulinism; Insulin; Insulin Resistance; Insulin-Secreting Cells; Mice | 2019 |